A range of bio-similar and recombinant protein products and processes is available at ARTES for out-licensing and technology transfer. With trainings or on-site support we assist our clients to implement the processes in their own labs respectively plants.

We transfer licenses on our intellectual property (IP) and know-how, on cell lines and on our developed processes.

For out-licensing we mutually agree with our partner on the terms and conditions in a case by case business model: non-exclusive or exclusive, regional or global licenses, lump-sum payments or milestone based payments.

Together with our client we find out the most efficient model.